You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 24, June 27, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Medical Ethics
 •Alert me on articles by topic

Ethical Implications of a New Application of Preimplantation Diagnosis

Marian D. Damewood, MD

JAMA. 2001;285:3143-3144.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Several thousand known genetic mutations are associated with specific inherited human diseases, and certain single-gene defects are now amenable to preventive intervention by preimplantation genetic diagnosis (PGD). In the past, couples wishing to ensure that a genetic disease did not affect their fetus had the option of prenatal diagnosis by amniocentesis or chorionic villus sampling. The technology of PGD spares the couple the difficult decision of subsequent clinical abortion, because only embryos that do not have the potential to develop a genetic disease are transferred to the woman's uterus for implantation.1 However, the procedure of PGD, as well as the issue of embryo selection and discard, has generated multiple ethical questions regarding the technology and applications. In addition, reservations about PGD use and potential abuse with selecting a pregnancy with particular genetic parameters have raised important ethical concerns.

The aim of PGD, developed in the mid . . . [Full Text of this Article]

Author Affiliations: Department of Obstetrics and Gynecology, Women and Children Services, WellSpan Health, York Hospital, York, Pa; The Johns Hopkins University School of Medicine, Baltimore, Md.


RELATED ARTICLE

Preimplantation Diagnosis for Fanconi Anemia Combined With HLA Matching
Yury Verlinsky, Svetlana Rechitsky, William Schoolcraft, Charles Strom, and Anver Kuliev
JAMA. 2001;285(24):3130-3133.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Britain's new preimplantation tissue typing policy: an ethical defence
Ram
J. Med. Ethics 2006;32:278-282.
FULL TEXT  

Preimplantation HLA Testing
Verlinsky et al.
JAMA 2004;291:2079-2085.
ABSTRACT | FULL TEXT  

Fanconi anaemia
Tischkowitz and Hodgson
J. Med. Genet. 2003;40:1-10.
ABSTRACT | FULL TEXT  

Preimplantation Diagnosis for Early-Onset Alzheimer Disease Caused by V717L Mutation
Verlinsky et al.
JAMA 2002;287:1018-1021.
ABSTRACT | FULL TEXT  

Preimplantation Genetic Diagnosis of Fanconi's Anemia
JWatch General 2001;2001:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.